Hedge Fund and Insider Trading News: John Paulson, Sandell Asset Management, Coda Octopus Group, Inc. (CODA), Vitamin Shoppe Inc (VSI), and More
Call John Paulson the Piano Man.
Hedge Fund - Paulson & Co
News, Interviews, and Investor Letters
- First
- << Previous
- 91 - 100
- Next >>
13G Filing: Paulson & Co and Synergy Pharmaceuticals Inc. (SGYP)
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing ...
13G Filing: Paulson & Co and Enzymotec Ltd (ENZY)
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing ...
13D Filing: Paulson & Co and Valeant Pharmaceuticals International Inc. (VRX)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f...
13D Filing: Paulson & Co and Overseas Shipholding Group Inc (OSG)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f...
13D Filing: Paulson & Co and Valeant Pharmaceuticals International Inc. (VRX)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f...
Can Hedge Funds See Into The Future?
In this article, Insider Monkey looks at the long-term performance of hedge funds' most popular stock picks with particular interest.
13D Filing: Paulson & Co and Extended Stay America Inc. (STAY)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f...
13D Filing: Paulson & Co and Esh Hospitality Inc.
If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f...
3 Hedge Funds Still Love Valeant Pharmaceuticals Intl Inc (VRX)
Pershing Square Capital Management, managed by Bill Ackman, sold its entire stake in Valeant Pharmaceuticals Intl Inc (NYSE:VRX) on Monday.
- First
- << Previous
- 91 - 100
- Next >>